Recent epidemiology attests that hypertriglyceridemia may be a causal risk factor for cardiovascular disease (CVD). The specific atherogenicity of hypertriglyceridemia relates to the accumulation in plasma of triglyceride-rich lipoprotein remnants. Hypertriglyceridemia also drives a 'global' atherogenic dyslipidemic profile, which is frequent in high-risk cardiovascular patients, such as Type 2 diabetics. Elevated triglyceride in fasting or nonfasting blood samples should be a trigger for ass...Expand abstract
- Publisher copy:
- Copyright date:
Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient?
If you are the owner of this record, you can report an update to it here: Report update to this record